SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 64 filers reported holding SORRENTO THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,703,019 | -59.8% | 1,922,143 | -28.7% | 0.00% | -66.7% |
Q3 2022 | $4,232,000 | +18.2% | 2,695,925 | +51.4% | 0.00% | 0.0% |
Q2 2022 | $3,579,000 | +249.9% | 1,780,555 | +305.5% | 0.00% | +200.0% |
Q1 2022 | $1,023,000 | -71.3% | 439,090 | -42.7% | 0.00% | -50.0% |
Q4 2021 | $3,562,000 | +33.0% | 766,089 | +118.3% | 0.00% | 0.0% |
Q3 2021 | $2,678,000 | -51.5% | 350,959 | -38.4% | 0.00% | -33.3% |
Q2 2021 | $5,517,000 | +38.1% | 569,380 | +17.9% | 0.00% | 0.0% |
Q1 2021 | $3,995,000 | +330.0% | 483,066 | +255.3% | 0.00% | – |
Q4 2020 | $929,000 | -6.2% | 135,951 | +53.0% | 0.00% | – |
Q3 2020 | $990,000 | -14.4% | 88,842 | -51.8% | 0.00% | -100.0% |
Q2 2020 | $1,156,000 | +1170.3% | 184,134 | +273.7% | 0.00% | – |
Q1 2020 | $91,000 | -7.1% | 49,275 | +69.5% | 0.00% | – |
Q4 2019 | $98,000 | +206.2% | 29,078 | +96.3% | 0.00% | – |
Q3 2019 | $32,000 | -67.3% | 14,814 | -59.6% | 0.00% | – |
Q2 2019 | $98,000 | -41.7% | 36,672 | +3.4% | 0.00% | – |
Q1 2019 | $168,000 | -92.0% | 35,470 | -96.0% | 0.00% | -100.0% |
Q4 2018 | $2,113,000 | +47.5% | 880,598 | +170.3% | 0.00% | +100.0% |
Q3 2018 | $1,433,000 | -8.3% | 325,729 | +50.0% | 0.00% | 0.0% |
Q2 2018 | $1,563,000 | +46.1% | 217,100 | +4.5% | 0.00% | 0.0% |
Q1 2018 | $1,070,000 | +1918.9% | 207,758 | +1384.0% | 0.00% | – |
Q4 2017 | $53,000 | +657.1% | 14,000 | +250.0% | 0.00% | – |
Q3 2017 | $7,000 | -30.0% | 4,000 | -20.0% | 0.00% | – |
Q2 2017 | $10,000 | -58.3% | 5,000 | -17.8% | 0.00% | – |
Q1 2017 | $24,000 | -17.2% | 6,084 | +4.0% | 0.00% | – |
Q4 2016 | $29,000 | -35.6% | 5,850 | 0.0% | 0.00% | – |
Q3 2016 | $45,000 | +32.4% | 5,850 | -2.5% | 0.00% | – |
Q2 2016 | $34,000 | -69.6% | 6,000 | -71.3% | 0.00% | – |
Q1 2016 | $112,000 | -13.2% | 20,883 | +40.9% | 0.00% | – |
Q4 2015 | $129,000 | +134.5% | 14,818 | +125.4% | 0.00% | – |
Q3 2015 | $55,000 | +14.6% | 6,573 | +139.3% | 0.00% | – |
Q2 2015 | $48,000 | +77.8% | 2,747 | +15.5% | 0.00% | – |
Q1 2015 | $27,000 | – | 2,378 | +5430.2% | 0.00% | – |
Q4 2014 | $0 | -100.0% | 43 | -98.5% | 0.00% | – |
Q3 2014 | $13,000 | – | 2,900 | +16011.1% | 0.00% | – |
Q2 2014 | $0 | – | 18 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 6,000,000 | $66,900,000 | 2.57% |
SABBY MANAGEMENT, LLC | 606,298 | $6,760,000 | 1.01% |
Virtus ETF Advisers LLC | 66,851 | $745,000 | 0.39% |
Newbridge Financial Services Group, Inc. | 26,900 | $300,000 | 0.30% |
Avidian Wealth Solutions, LLC | 330,000 | $3,680,000 | 0.28% |
Spectrum Wealth Advisory Group, LLC | 36,692 | $422,000 | 0.27% |
COWEN AND COMPANY, LLC | 129,200 | $1,441,000 | 0.24% |
Cormorant Asset Management, LP | 500,000 | $5,575,000 | 0.21% |
SYMMETRY PEAK MANAGEMENT LLC | 27,500 | $307,000 | 0.20% |
Aristides Capital LLC | 24,302 | $271,000 | 0.19% |